Have questions for our experts or want more information?
Contact Us Today
Webinar Overview: iPSC Differentiation and Regulation Insights
The landscape of cell therapy development is being transformed with the increased use of induced pluripotent stem cells (iPSCs). They serve as powerful cellular starting materials, but they also come with the challenge of finding effective protocols for differentiation, especially if you’re interested in iPSC-derived cardiomyocytes and immune cells. Coupled with concerns over uncontrolled proliferation, genetic mutations, and other safety risks, iPSCs present some hurdles that could cause a problem in your development.
In this webinar, experts from Pluristyx® tackle these important concerns by sharing their scientific insights on successful methods for differentiating and regulating human iPSCs.
You will learn about:
- iPSC use cases in cell therapy development and regenerative medicine
- Efficient methods for differentiating iPSCs into natural killer cells and cardiomyocytes
- Using FailSafe® kill switch system to remove unwanted iPSCs from differentiated cells
Webinar Presenters
Benjamin Fryer, PhD
Chief Executive Officer
Pluristyx
Christina Jones, PhD
Technical Applications Scientist
Pluristyx